miR-5000-3p confers oxaliplatin resistance by targeting ubiquitin-specific peptidase 49 in colorectal cancer

miR-5000-3p confers oxaliplatin resistance by targeting ubiquitin-specific peptidase 49 in colorectal cancer

Abstract Colorectal cancer (CRC) is the most common form of gastrointestinal malignancies. A growing number of reports focusing on oxaliplatin (OXA) resistance in CRC treatment have revealed that drug resistance is an urgent issue in clinical applications, especially for finding effective therapeuti...

Full description

Bibliographic Details
Main Authors: Yan-yan Zhuang, Wa Zhong, Zhong-sheng Xia, Shu-zhen Lin, Man chung Chan, Ke Jiang, Wen-fei Li, Xin-yi Xu
Format: Article
Language:English
Published: Nature Publishing Group 2021-06-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-021-00494-0

Similar Items

Similar Items